Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
Staff members work at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
A staff member shows a COVID-19 antigen self-testing kit at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
A staff member works at a production line of COVID-19 self-testing kits at Biouhan healthcare company in Hefei, east China’s Anhui Province, March 29, 2022. Since March 11, China has added antigen detection as an option for COVID-19 testing among the public. Such kits are already seen in drug stores, online platforms and multiple detection scenarios in China. With a capacity of up to 10 million kits per day, Biouhan healthcare company is a major manufacturer of COVID-19 antigen self-testing kits in east China’s Anhui Province. The testing kits have been used in transportation hubs in Hefei, Anhui Province. (Xinhua/Du Yu)
原文地址：http://en.people.cn/n3/2022/0403/c90000-10079656.html